RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Subarachnoid Hemorrhage
Accession: DOID:9000438
browse the term
Definition: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
Synonyms: exact_synonym: Aneurysmal Subarachnoid Hemorrhage; Aneurysmal Subarachnoid Hemorrhages; Intracranial Subarachnoid Hemorrhage; Intracranial Subarachnoid Hemorrhages; Perinatal Subarachnoid Hemorrhage; Perinatal Subarachnoid Hemorrhages; SAH (Subarachnoid Hemorrhage); SAHs (Subarachnoid Hemorrhage); Spontaneous Subarachnoid Hemorrhage; Spontaneous Subarachnoid Hemorrhages; Subarachnoid Hemorrhages
primary_id: MESH:D013345
xref: EFO:0000713 ; NCI:C50757
G
Abcc8
ATP binding cassette subfamily C member 8
treatment
IMP
RGD
PMID:24114458
RGD:10003028
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:96,598,647...96,679,510
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:22230897
RGD:8695949
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18950269
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA, protein:increased expression:brain
RGD
PMID:24291745
RGD:8696000
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Aif1
allograft inflammatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Apoe
apolipoprotein E
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Aqp4
aquaporin 4
exacerbates
IEP IMP
mRNA:increased expression:brain:
RGD
PMID:33574749 PMID:33574749
RGD:127284879 , RGD:127284879
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Aqp4em1Hrt
aquaporin 4; TALEN induced mutant 1, Hrt
exacerbates
IMP
RGD
PMID:33574749
RGD:127284879
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:26163325
RGD:13782347
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Becn1
beclin 1
IEP
protein:increased expression:brain
RGD
PMID:22521819
RGD:6483046
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bnip3
BCL2 interacting protein 3
treatment
IEP
RGD
PMID:23850688
RGD:11561986
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP
RGD
PMID:26518242
RGD:11040780
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Casp3
caspase 3
treatment
ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24602480 PMID:26163325
RGD:13782347
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
treatment
IDA
RGD
PMID:26163325
RGD:13782347
Ensembl chr 5:154,109,046...154,126,626
G
Ccl20
C-C motif chemokine ligand 20
IEP
mRNA:increased expression:cerebral artery
RGD
PMID:17977275
RGD:7488893
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA:increased expression:lung
RGD
PMID:20731855
RGD:4145368
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cybb
cytochrome b-245 beta chain
IEP
Protein:increased expression:cerebral cortex mRNA:increased expression:cerebral vessel:
RGD
PMID:16671452 PMID:12142572
RGD:1599680 , RGD:11040582
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
ISO
DNA:snp:cds:p.I118V (human)
RGD
PMID:18566305
RGD:5685415
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Ddit3
DNA-damage inducible transcript 3
treatment
IEP
RGD
PMID:30226536
RGD:35316073
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8587695
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Ednrb
endothelin receptor type B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8587695
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:23907045
RGD:10400909
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Erbb4
erb-b2 receptor tyrosine kinase 4
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:69,531,481...70,596,595
G
Ern1
endoplasmic reticulum to nucleus signaling 1
treatment
IMP IEP
RGD
PMID:29169414 PMID:30226536
RGD:34901873 , RGD:35316073
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029
G
Esr1
estrogen receptor 1
IEP
protein:increased expression:dentate gyrus
RGD
PMID:23465388
RGD:8553242
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Gli1
GLI family zinc finger 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:23933201
RGD:12859044
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:63,156,926...63,169,251
G
Gpx3
glutathione peroxidase 3
ISO
protein:increased expression:plasma
RGD
PMID:32326289
RGD:401827845
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:27026509
RGD:13792767
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
disease_progression severity
IEP ISO
mRNA, protein:altered expression:cerebral cortex (rat) protein:decreased expression:blood plasma (human)
RGD
PMID:25744577 PMID:23880145
RGD:11055426 , RGD:329333027
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
IEP
mRNA,protein:decreased expression:hippocampus:
RGD
PMID:22378889
RGD:9686397
NCBI chr 2:51,228,710...51,632,806
Ensembl chr 2:49,495,771...49,899,774
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:brain
RGD
PMID:15703702
RGD:1626323
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
IMP IEP ISO
mRNA:increased expression:subarachnoid space
RGD
PMID:16543643 PMID:19686725 PMID:14657544
RGD:1582702 , RGD:4145300 , RGD:1598406
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspd1
heat shock protein family D (Hsp60) member 1
IEP
mRNA:increased expression:brain stem
RGD
PMID:14753490
RGD:1624246
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Htr1b
5-hydroxytryptamine receptor 1B
IEP
RGD
PMID:17542534
RGD:1626451
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Icam1
intercellular adhesion molecule 1
IEP
mRNA:increased expression:lung (rat)
RGD
PMID:20731855
RGD:4145368
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
rat model treated with human protein
RGD
PMID:22679224
RGD:7051590
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irf9
interferon regulatory factor 9
ameliorates
IMP
RGD
PMID:29480757
RGD:125093745
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:29,095,789...29,101,236
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
treatment
IEP
RGD
PMID:22420318
RGD:8662908
NCBI chr13:87,334,510...87,367,747
Ensembl chr13:84,802,009...84,835,461
G
Lcn2
lipocalin 2
ameliorates
ISO
RGD
PMID:26463936
RGD:126781835
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IEP
RGD
PMID:30226536
RGD:35316073
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
treatment
IEP
RGD
PMID:29273596
RGD:155804269
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mmp1
matrix metallopeptidase 1
no_association
ISO
RGD
PMID:11546917
RGD:1582365
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
IDA
RGD
PMID:16961140
RGD:1582545
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
IDA
RGD
PMID:22475348
RGD:8657107
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27157545 PMID:17410600
RGD:1642039
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22304528
RGD:10412722
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Ngb
neuroglobin
IEP
protein:increased expression:cerebral cortex
RGD
PMID:24281943
RGD:9743950
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
G
Nlk
nemo like kinase
disease_progression
IEP
RGD
PMID:23325309
RGD:12791279
NCBI chr10:63,467,388...63,590,960
Ensembl chr10:63,438,222...63,589,730
G
Nos2
nitric oxide synthase 2
ISO
mRNA:increased expression:brainstem, basilar artery (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17053178 PMID:21915076
RGD:5509046
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
IEP
mRNA:increased expression:parietal cortex, arteriole (rat)
RGD
PMID:11273938
RGD:7794687
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nqo1
NAD(P)H quinone dehydrogenase 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:21259333
RGD:5133235
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nrg1
neuregulin 1
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Ntn1
netrin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29162556
NCBI chr10:52,899,933...53,098,591
Ensembl chr10:52,899,934...53,085,326
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IDA
RGD
PMID:21193742
RGD:5684779
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Pdcd10
programmed cell death 10
IEP
protein:decreased expression:brain, microglial cell (rat)
RGD
PMID:32302649
RGD:401827168
NCBI chr 2:162,602,516...162,644,690
Ensembl chr 2:160,303,449...160,346,018
G
Pdgfrb
platelet derived growth factor receptor beta
ameliorates
IMP
RGD
PMID:29480757
RGD:125093745
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:99,594,644...99,699,663
G
Pkd1l1
polycystin 1 like 1, transient receptor potential channel interacting
susceptibility
ISO
DNA:polymorphism:cds:p.Gly243Asp(human)
RGD
PMID:16741147
RGD:155630602
NCBI chr14:83,552,964...83,670,062
Ensembl chr14:83,545,469...83,638,498
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29162556
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Prkn
parkin RBR E3 ubiquitin protein ligase
treatment
IEP
RGD
PMID:28546552
RGD:13432565
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555
G
Ptch1
patched 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:23933201
RGD:12859044
NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,542,877...1,607,333
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21725746
RGD:5508204
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Shh
sonic hedgehog signaling molecule
IEP
mRNA, protein:increased expression:brain
RGD
PMID:23933201
RGD:12859044
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:6,954,017...6,963,170
G
Smo
smoothened, frizzled class receptor
treatment
IDA
RGD
PMID:28149272
RGD:150521623
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:58,343,529...58,373,829
G
Stat3
signal transducer and activator of transcription 3
IEP
mRNA, protein:increased expression, increased phosphorylation:cerebral artery
RGD
PMID:24517975
RGD:8694356
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Tacr1
tachykinin receptor 1
IMP
RGD
PMID:17542534
RGD:1626451
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:114,920,844...115,089,733
G
Tjp1
tight junction protein 1
IDA
protein:altered localization
RGD
PMID:18854840
RGD:2325137
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tlr4
toll-like receptor 4
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19719951
RGD:4144093
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tmbim6
transmembrane BAX inhibitor motif containing 6
treatment
IDA IEP
mRNA,protein:decreased expression:brain
RGD
PMID:30226536 PMID:30226536
RGD:35316073 , RGD:35316073
NCBI chr 7:132,405,217...132,422,492
Ensembl chr 7:130,527,316...130,543,633
G
Tnc
tenascin C
IEP
protein:increased expression:basilar artery
RGD
PMID:19589197
RGD:4889600
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
IEP ISO
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27157545 PMID:19719951
RGD:4144093
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Trem1
triggering receptor expressed on myeloid cells 1
treatment severity
IEP ISO
RGD
PMID:30910643 PMID:33727099
RGD:127284863 , RGD:127284864
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:12,763,819...12,779,203
G
Trpm4
transient receptor potential cation channel, subfamily M, member 4
IEP
protein:increased expression:entorhinal cortex
RGD
PMID:24114458
RGD:10003028
NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532
G
Unc5b
unc-5 netrin receptor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29162556
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Yap1
Yes1 associated transcriptional regulator
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr 8:13,380,551...13,451,640
Ensembl chr 8:5,095,722...5,167,010
G
Abcc8
ATP binding cassette subfamily C member 8
treatment
IMP
RGD
PMID:18854840
RGD:2325137
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:96,598,647...96,679,510
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all